Upgrade to SI Premium - Free Trial

Omnicell (OMCL) Reiterated at Buy by Benchmark After Investor, CEO Meet

March 13, 2026 7:14 AM
Benchmark analyst Bill Sutherland reiterated a Buy rating and $60.00 price target on Omnicell (NASDAQ: OMCL).The analyst commented, "This week ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments